ReviewHeliyon2024
Ochratoxin A in food commodities: A review of occurrence, toxicity, and management strategies.
Review in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
28 citing papers in PubMed.
- Article
- Impacts of Fungal Infection and Mycotoxin Contamination on Nutritional Quality and Safety of Protein-Rich Pulses.Food safety (Tokyo, Japan) · 2026Article
- Article
- Nanostructured and bio based high performance adsorbents for the purification of water and food matrices from emerging contaminants.RSC advances · 2026Review
- Nanoparticle-Induced Interfacial Director Straining Enables Ultrasensitive Molecular Detection at Microfluidic Liquid Crystal Interfaces.ACS applied materials & interfaces · 2026Article
- Article
- Weather-Related Variations of Mycotoxins in Maize: A 2024 Study from AP Vojvodina (Serbia) and the Republic of Srpska (Bosnia and Herzegovina).Foods (Basel, Switzerland) · 2026Article
- Highly sensitive detection of ochratoxin A by fluorescence polarization assay based on rolling circle amplification.Analytical and bioanalytical chemistry · 2026Article
- Viability of Commercially Available Rapid Test Strips for Mycotoxin Analysis Compared to Chromatographic Methods.Toxins · 2026Article
- Biological Detoxification of Mycotoxins by Lactic Acid Bacteria: Safeguarding Food from Fungal Contaminants.Toxins · 2026Review
- Detoxification of Ochratoxin A byFoods (Basel, Switzerland) · 2026Article
- Article
- Article
- Role of LONP1 in human diseases: molecular mechanisms and therapeutic potential.Cellular & molecular biology letters · 2026Review
- Isolation and Characterization ofFoods (Basel, Switzerland) · 2026Article
- Probiotics as eco-friendlybio-preservatives: In vivo mechanisms of mycotoxin inhibition and emerging applications for food safety and human health.Mycotoxin research · 2025Review
- Investigating the binding mechanism of aptamers to ochratoxin A and development of competitive colorimetric sensing platforms.Mikrochimica acta · 2025Article
- Comprehensive IAC Cross-Reactivity Validation and Stabilized Method Development for Ochratoxin A, B, and C in Complex Coffee and Spice Matrices.Foods (Basel, Switzerland) · 2025Article
- Bioinformatic based protein-ochratoxin A screening studies and fabrication of a protein-based electrochemical sensor for specific detection of ochratoxin A in food samples.Mikrochimica acta · 2025Article
- Mycotoxins in food and agriculture: from occurrence to economic consequences.Archives of microbiology · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ochratoxin A (OTA) is a potent mycotoxin produced by species of Aspergillus and Penicillium that contaminate agricultural products and pose significant health risks to both humans and animals. This review examines the mechanisms of OTA toxicity, its occurrence in various food commodities, and the implications for public health and trade. Literature pertaining to OTA was sourced from Google Scholar, covering the period from 2004 to 2024. OTA exposure is linked to multiple adverse health effects, including teratogenicity, immunotoxicity, and hepatotoxicity, with a primary impact on kidney function, and it is classified as a possible human carcinogen (Group 2B). Its toxic effects are attributed to several mechanisms, including lipid peroxidation, inhibition of protein synthesis, DNA damage, oxidative stress, and mitochondrial dysfunction. Notable findings included the presence of OTA in 46.7 % of cocoa products in Turkey, 32 % of cocoa samples in Côte d'Ivoire exceeding the OTA threshold of 2 μg/kg, and 91.5 % of ready-to-sell cocoa beans in Nigeria testing positive for OTA. Coffee beans are particularly susceptible to OTA contamination, which underscores the need for vigilant monitoring. Additionally, OTA contamination impacts agricultural productivity and food safety, leading to significant economic consequences, particularly in regions reliant on exports, such as cocoa and coffee. Several countries regulate the OTA levels in food products to safeguard public health. However, these regulations can impede trade, particularly in countries with high levels of contamination. Balancing regulatory compliance with economic viability is crucial for affected nations. Current strategies for managing OTA include improved agronomic practices, such as the use of biocontrol agents for pest management, enhanced storage conditions to prevent mould growth, and the implementation of detoxification techniques to reduce OTA levels in food products. Despite these strategies, OTA remains a significant threat to public health and the agricultural economy worldwide. The complexity of contamination in food products requires robust prevention, control, and management strategies to mitigate its impact. Continuous research and regulatory initiatives are essential for safeguarding consumers and ensuring food safety.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.